质子抑制剂使用与偏头痛风险之间的剂量依赖关系:一项全国匹配的病例控制研究
Yuan-Zhen Ruan1, Fu-Chi Yang1, Ya-Mei Bai2,3
1Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Chenggong Rd., Neihu District, Taipei City 114202, Taiwan.
Postgraduate medical journal
|May 19, 2025
概括
质子抑制剂 (PPI) 的使用与亚洲人群中偏头痛风险更高有关. 增加的PPI暴露显示出与偏头痛发展的剂量依赖关系,需要仔细监测.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 质子抑制剂 (PPI) 在全球范围内经常被处方.
- 防护剂使用与偏头痛风险之间的关联,特别是在亚洲人口中,需要进一步调查.
研究的目的:
- 为了确定PPI暴露与偏头痛风险增加是否相关.
- 评估这种风险是否依赖于剂量,并根据亚洲人口的偏头痛亚型和PPI指示而有所不同.
主要方法:
- 一项匹配的病例控制研究利用了台湾国家健康保险研究数据库 (2000-2015年).
- 包括针对特定胃肠道疾病的成人PPI使用者,对照组根据年龄,性别和居住地进行匹配.
- 使用累积定义每日剂量 (cDDDs) 来量化PPI暴露.
主要成果:
- 该研究分析了22,834名参与者,平均随访时间为4.1年.
- 随着 PPI 累积暴露的增加 (cDDD >30),观察到偏头痛风险的显著逐步增加.
- 这种剂量依赖的关联在不同偏头痛亚型和PPI使用原因中保持一致.
结论:
- 在亚洲人群中,PPI暴露与偏头痛风险增加之间存在显著的剂量依赖关系.
- 医疗保健提供者应谨慎处方长期PPI,并监测偏头痛症状,特别是在亚洲患者.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
320
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
320
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
53
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
53
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
327
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
327
Dose-Response Relationship: Selectivity and Specificity
6.3K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
322
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
322
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
378
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
378


